Fresenius Medical Care (NYSE: FMS) reported Q4 EPS of EUR1.44. Revenue for the quarter came in at EUR5.07 billion.

Outlook 2026
In 2026, Fresenius Medical Care expects revenue growth to be broadly flat compared to prior year.
The company expects operating income to remain on a consistent level, with a range between a positive and negative mid-single digit percent growth rate compared to prior year.
The expected growth rates for 2026 are at constant currency and excluding special items in operating income. The 2025 basis for the revenue outlook is EUR 19,628 million and for the operating income outlook is EUR 2,212 million.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.